STK16
| Official symbol: | STK16 |
| Full name: | serine/threonine kinase 16 |
| Location: | 2q35 |
| Also known as: | MPSK, PKL12 |
| Entrez ID: | 8576 |
| Ensembl ID: | ENSG00000115661 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.83 (Driver) |
|
|
|
| Recurrently deleted in 4 cancer type(s) |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 2 |
|
|
| Fusions detected in 2 cancer type(s) |
|
| |
|
|
|
| Functional class: | Kinase (protein kinase) |
| JensenLab PubMed score: | 71.46 (Percentile rank: 67.65%) |
| PubTator score: | 19.43 (Percentile rank: 51.81%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | |
